(Q35195815)

7 August 2017

title

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis (English)

1 reference

7 August 2017

1 reference

3

Anat Mirelman

1 reference

7 August 2017

Rachel Saunders-Pullman

14

object named as

Rachel Saunders-Pullman

1 reference

7 August 2017

4

Nir Giladi

1 reference

7 August 2017

12

Avi Orr-Urtreger

1 reference

7 August 2017

2

Marta San Luciano

1 reference

7 August 2017

10

Javier Ruiz-Martinez

1 reference

7 August 2017

José Félix Martí Massó

11

object named as

Jose Felix Marti-Masso

1 reference

7 August 2017

13

Susan Bressman

1 reference

7 August 2017

Ilir Agalliu

1

1 reference

7 August 2017

Bjorg Waro

5

1 reference

7 August 2017

Jan Aasly

6

1 reference

7 August 2017

Rivka Inzelberg

7

1 reference

7 August 2017

Sharon Hassin-Baer

8

1 reference

7 August 2017

Eitan Friedman

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

7 August 2017

1 reference

7 August 2017

volume

72

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

58-65

1 reference

Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Parkinson's disease and cancer: two wars, one front

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Parkinson's disease and cancer risk: a systematic review and meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Family history of melanoma and Parkinson disease risk

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

New biochemical approaches towards understanding the Parkinson's disease-associated kinase, LRRK2.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Are Parkinson disease patients protected from some but not all cancers?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Implications for estrogens in Parkinson's disease: an epidemiological approach.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Kinase activity of mutant LRRK2 mediates neuronal toxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Atypical cancer pattern in patients with Parkinson's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

The common PARK8 mutation LRRK2G²⁰¹⁹S is not a risk factor for breast cancer in the absence of Parkinson's disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain).

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Meta-analysis of the relationship between Parkinson disease and melanoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Risk of Parkinson disease in women: effect of reproductive characteristics.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4366130

Mortality and cancer incidence in patients with Parkinson's disease

26 September 2018

1 reference

12 December 2020

Parkinson's disease and cancer: the unexplored connection

1 reference

12 December 2020

Are Parkinson disease patients protected from some but not all cancers?

1 reference

12 December 2020

High prevalence of malignant melanoma in Israeli patients with Parkinson's disease

1 reference

12 December 2020

Multiple primary melanoma following administration of levodopa

1 reference

12 December 2020

Parkinson's disease genes do not segregate with breast cancer genes' loci

1 reference

12 December 2020

Shared Predispositions of Parkinsonism and Cancer

1 reference

12 December 2020

Age at menopause predicts age at onset of Parkinson's disease

1 reference

12 December 2020

Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome

1 reference

12 December 2020

10.1001/JAMANEUROL.2014.1973

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference